Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:28 AM
Ignite Modification Date:
2025-12-25 @ 1:28 AM
NCT ID:
NCT04055194
Eligibility Criteria:
Inclusion Criteria:
* Gestational age 28 weeks of gestation.
* Definite and reliable diagnosis of placenta previa (defined as presence of a placenta within 2 cm of the internal os), using transvaginal ultrasound scan.
* Haemodynamically stable pregnant women.
* Maternal age:20-40years old.
* Pregnant women with placenta previa, and had previous bleeding attacks or admitted with antepartum haemorrhage.
Exclusion Criteria:
* Multiple pregnancy.
* Women with bleeding tendency due to any medical disorder (ITP, thrombocytopenia, coagulopathies),or on anticoagulants .
* Severe antepartum hemorrhage and/or hemodynamic instability that necessitates urgent intervention and delivery.
* Women have hypersensitivity or any contraindication to use of tranexamic acid.
* Pregnant women with placenta previa with doppler showing morbidly adherent placenta.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
20 Years
Maximum Age:
40 Years
Study:
NCT04055194
Study Brief:
Protocol Section:
NCT04055194